Research Article
Blood Pressure Control and Associated Factors among Hypertension Comorbid Type 2 Diabetic Patients in Southeast Ethiopia
Table 4
Utilization of antihypertensive and hypoglycemic agents among study participants at Bale Zone selected public hospitals, 2020 (n = 378).
| Medications | Frequency | Percentage |
| Monotherapy (antihypertensive drug) | Nifedipine | 22 | 5.8 | Amlodipine | 47 | 12.4 | Hydrochlorothiazide | 6 | 1.6 | Atenolol | 5 | 1.3 | Enalapril | 40 | 10.6 |
| Dual therapy (antihypertensive drug) | Enalapril + amlodipine | 113 | 29.9 | Hydrochlorothiazide + enalapril | 73 | 19.3 | Enalapril + atenolol | 32 | 8.5 | Hydrochlorothiazide + atenolol | 12 | 3.2 |
| Triple therapy (antihypertensive drug) | Enalapril + amlodipine + hydrochlorothiazide | 18 | 4.8 | Furosemide + enalapril + amlodipine | 10 | 2.7 |
| Antidiabetic agents (drugs) | Oral hypoglycemic agent | 213 | 56.4 | Insulin | 141 | 37.2 | Insulin + oral hypoglycemic agent | 24 | 6.4 |
|
|